CBNK insider sale notice: 40,000 common shares planned for Aug 26, 2025

Rhea-AI Filing Summary

Capital Bancorp, Inc. (CBNK) filed a Form 144 notifying the proposed sale of 40,000 shares of common stock through Keefe, Bruyette & Woods on NASDAQ, with an aggregate market value of $1,374,906.48 and approximately 16,583,541 shares outstanding. The securities were originally acquired on June 24, 2013 as a purchase of 10,000 shares for $17 per share that later split into 40,000 shares. The filing lists an approximate sale date of August 26, 2025. The filer reports no sales of issuer securities in the past three months and includes the standard attestation that no undisclosed material adverse information is known.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for 40,000 shares, small relative to outstanding shares; likely neutral for valuation.

The Form 144 documents a planned sale of 40,000 common shares valued at $1.37 million, representing roughly 0.24% of the stated outstanding shares (40,000/16,583,541). The filing shows the shares were acquired in 2013 and resulted from a split of an original purchase. No other recent sales are reported. Given the small proportion of outstanding shares and absence of recent trading activity disclosures, this appears to be a routine Section 144 notice rather than a material shift in ownership or control.

Corporate Governance Expert

TL;DR: Compliance filing meets Rule 144 disclosure requirements; contains standard attestation about material information.

The notice supplies required details: broker name and address, acquisition date and consideration, aggregate market value, and intended sale date. The filer attests no undisclosed material adverse information and reports no sales in the prior three months, which supports compliance with required aggregation and timing rules. There are no indications in the form of related-party transactions, plan-adoption dates, or other governance issues that would elevate investor concern from this filing alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Keefe, Bruyette & Woods 787 Seventh Avenue, 4th Floor New York, New York NY 10019	40000	1374906.48	16583541	08/26/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/24/2013	purchase	n/a			10000	06/24/2013	$17 cash per share for 10,000 shares, which split into 40,000 shares

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by Capital Bancorp (CBNK) disclose?

The Form 144 discloses a proposed sale of 40,000 common shares on NASDAQ through Keefe, Bruyette & Woods with an aggregate market value of $1,374,906.48 and an approximate sale date of 08/26/2025.

How many shares outstanding does Capital Bancorp report in the filing?

The filing lists 16,583,541 shares outstanding.

When and how were the securities being sold originally acquired?

The securities were acquired on 06/24/2013 by purchase: 10,000 shares at $17 per share, which later split into 40,000 shares.

Did the filer report any sales of issuer securities in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Who is the broker named in the Form 144 for CBNK's proposed sale?

The broker listed is Keefe, Bruyette & Woods, 787 Seventh Avenue, 4th Floor, New York, NY 10019.